Sue G. Griffith

Royal Brompton Hospital — United Kingdom

Medicine · Health Sciences

7h-index2.6kcitations16works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(4), Parkinson's Disease Mechanisms and Treatments(3), Nuclear Receptors and Signaling(3), Dementia and Cognitive Impairment Research(2), Reproductive Health and Contraception(2)

Publications16 total

2401Cardiac resinchronization therapy for the systemic right ventricle: a single center experience
European Heart Journal·2019
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease
JAMA Neurology·2018· 283 citedOpen Access
Results from a phase 1b multiple ascending-dose study of PRX002/RG7935, an Anti-alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease
Parkinsonism & Related Disorders·2018· 4 cited
First‐in‐human assessment of PRX002, an anti–α‐synuclein monoclonal antibody, in healthy volunteers
Movement Disorders·2016· 242 citedOpen Access
OP0205 Clinical and Preclinical Assessment of The Anti-MCAM Monoclonal Antibody PRX003, A Potential Novel Treatment for Th17-Mediated Inflammatory Diseases
Annals of the Rheumatic Diseases·2016
Multiple Ascending Dose Study With the New Renin Inhibitor VTP-27999
Hypertension·2014· 47 cited
Tu1405 The Kappa-Opioid Receptor Agonist Asimadoline Remains Peripherally Restricted at Supra-Therapeutic Plasma Exposures
Gastroenterology·2012· 4 citedOpen Access
Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
Neurology·2005· 544 cited
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
Neurology·2005· 1.3k cited
Aβ42 immunization in Alzheimer's disease generates Aβ N-terminal antibodies
Annals of Neurology·2005· 129 cited
Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women
Clinical Therapeutics·2004· 51 cited
P2-196 Rates of hippocampal and brain atrophy, and ventricular enlargement, in Alzheimer's disease: a comparison of markers of progression
Neurobiology of Aging·2004
O4-05-07 Neuropsychological, CSF, and neuropathological effects of A-beta immunotherapy (AN1792) of Alzheimer's disease in an interrupted trial
Neurobiology of Aging·2004· 6 cited
P4-401 Characterization of the humoral response to AN1792 immunization in AD patients
Neurobiology of Aging·2004· 1 cited
O4-05-08 Effects of A-beta immunotherapy (AN1792) on MRI measures of brain, ventricle and hippocampal volumes in Alzheimer's disease
Neurobiology of Aging·2004· 6 cited
No effect of steady-state dosing of zonisamide on pharmacokinetics and pharmacodynamics of an oral contraceptive in healthy females
2004

Frequent Co-authors

Lisa Jenkins(5), Nick C. Fox(5), Ronald S. Black(5), Martin Koller(5), M. Köller(4), Daniel Ness(4), Gene G. Kinney(4), Martin N. Rossor(3), Dale B. Schenk(3), Wagner Zago(3), Michael Grundman(3), Susanne Ostrowitzki(3), S. Gilman(2), Merçé Boada(2), Jean‐Marc Orgogozo(2), Joseph Jankovic(2), Ira Goodman(2), Beth Safirstein(2), Jay Soto(2), Frank Boess(2)